NEXT
Sign in to follow

New Jersey Law Journal

Drugmakers Face Suits Linking Diabetes Med to Heart Failure

AstraZeneca Pharmaceuticals and Bristol-Myers Squibb were hit with 14 suits in the District of New Jersey on Tuesday claiming that users of diabetes drug saxagliptin face elevated risks of heart failure as a result of using the drug.
3 minute read

National Law Journal

J&J Fends Off Xarelto Claims in First Bellwether Trial

Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc. and Bayer brought in powerhouse litigator Beth Wilkinson of Washington, D.C.'s Wilkinson Walsh + Eskovitz to lead the defense team in the first of four bellwether trials.
4 minute read

New Jersey Law Journal

$25M Accutane Verdict Tossed Over Expert TestimonyLimits

A state appeals court tossed a $25 million verdict against Hoffmann-La Roche in a suit over acne drug Accutane after finding that the trial judge improperly restricted duplicative testimony from two defense experts.
11 minute read

The Legal Intelligencer

485 Pharmacies Sue Catamaran Successor Over Reimbursements

A group of 485 independently owned pharmacies nationwide has sued OptumRx, the successor company to Catamaran Corp. through a merger, claiming they were low-balled on reimbursements based on outdated pricing data.
2 minute read

The Legal Intelligencer

Expert Witness' Move to Aid Stricken Juror Leads to Risperdal Post-Trial Motion

Three weeks before the latest Risperdal case was tossed out midtrial, one of the jurors initially tasked with evaluating the claims collapsed while a plaintiff's expert was testifying on the stand.
8 minute read

National Law Journal

Appellate Court Won't Overhaul 'On-Sale' Patent Bar

The U.S. Court of Appeals for the Federal Circuit ruled a drug used to treat chemotherapy symptoms did not avoid the on-sale bar for patents despite keeping some details of its drug sale confidential.
3 minute read

New York Law Journal

US Judge Sanctions Milberg for Actions in Qui Tam Case

A federal judge in Massachusetts ruled Manhattan plaintiffs firm Milberg "implemented an elaborate scheme of misrepresentation and deceit under the guise of a legitimate medical research study" and dismissed a plaintiff's qui tam action.
14 minute read

New Jersey Law Journal

Third Circuit Won't Revive Avastin False Claims Case

There will be no second chance for a dismissed False Claims Act case pursued by a whistleblower and numerous government entities alleging that Genentech suppressed data about Avastin, a federal appeals court has decided.
3 minute read

New Jersey Law Journal

Mylan Faces Suits by Sanofi, Consumers Over EpiPen Pricing

Already under scrutiny from lawmakers over pricing of its EpiPen epinephrine injector, Mylan faces new lawsuits from consumers and a competitor in New Jersey federal courts accusing it of taking anti-competitive actions to protect its product's market share.
13 minute read

National Law Journal

First Xarelto Case to Test Views Over Attorney Ads

The first bellwether trial over blood thinner Xarelto began on Monday in New Orleans—but it's not just your ordinary case involving a pharmaceutical drug.
4 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • Why Embracing Change Is Essential for Your Legal Department

    Brought to you by DiliTrust

    Download Now

  • International Export and Trade Assistance State Law Survey

    Brought to you by LexisNexis®

    Download Now

  • How This Personal Injury Firm Reduced Client Intake Time by 80%

    Brought to you by PracticePanther

    Download Now

  • The Hidden Cost of Bad Reviews: Why Law Firms & Attorneys Can't Afford a Damaged Online Reputation

    Brought to you by Erase.com

    Download Now